Works by Simmons, Bryony
Results: 26
Evaluation of the psychometric properties of the HIV Disability Questionnaire among adults living with HIV in the United Kingdom: A cross-sectional self-report measurement study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0213222
- By:
- Publication type:
- Article
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.
- Published in:
- Frontiers in Reproductive Health, 2023, v. 5, p. 1, doi. 10.3389/frph.2023.1133556
- By:
- Publication type:
- Article
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 3, p. 1, doi. 10.1093/ofid/ofae007
- By:
- Publication type:
- Article
Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 12, p. 1, doi. 10.1093/ofid/ofac587
- By:
- Publication type:
- Article
INITIAL SUPPLEMENTAL DOLUTEGRAVIR DOSE IN SECOND-LINE ART: A PHASE 2 RANDOMISED TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 206
- By:
- Publication type:
- Article
BASELINE nRTI HIV DRUG RESISTANCE AND EFFECT ON RECYCLED nRTIs: THE VISEND TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 206
- By:
- Publication type:
- Article
STANDARD VS DOUBLE DOSE DOLUTEGRAVIR IN HIV-ASSOCIATED TUBERCULOSIS: WEEK 48 RESULTS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 45
- By:
- Publication type:
- Article
Progress towards antibiotic use targets in eight high-income countries.
- Published in:
- Bulletin of the World Health Organization, 2021, v. 99, n. 8, p. 550, doi. 10.2471/BLT.20.270934
- By:
- Publication type:
- Article
Prices of second-line antiretroviral treatment for middle-income countries inside versus outside sub-Saharan Africa.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19604
- By:
- Publication type:
- Article
Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 7, p. 928, doi. 10.1093/cid/ciu012
- By:
- Publication type:
- Article
Low CD4 counts predict excessive weight gains during first-line treatment for HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2369, doi. 10.1093/jac/dkae238
- By:
- Publication type:
- Article
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 10, p. 2706, doi. 10.1093/jac/dkac266
- By:
- Publication type:
- Article
Erratum Erratum to: Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa (DIAGMAL).
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0272847
- By:
- Publication type:
- Article
Multimodality assessment of sleep outcomes in people living with HIV performed using validated sleep questionnaires.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1832, doi. 10.1093/cid/ciad023
- By:
- Publication type:
- Article
Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 1, p. 87, doi. 10.1093/cid/ciy426
- By:
- Publication type:
- Article
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 6, p. 683, doi. 10.1093/cid/civ948
- By:
- Publication type:
- Article
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 5, p. 730, doi. 10.1093/cid/civ396
- By:
- Publication type:
- Article
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19801-x
- By:
- Publication type:
- Article
Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.
- Published in:
- 2017
- By:
- Publication type:
- journal article